AP1927A - Substituted indolepyridinium as anti-infective compounds - Google Patents

Substituted indolepyridinium as anti-infective compounds

Info

Publication number
AP1927A
AP1927A AP2005003334A AP2005003334A AP1927A AP 1927 A AP1927 A AP 1927A AP 2005003334 A AP2005003334 A AP 2005003334A AP 2005003334 A AP2005003334 A AP 2005003334A AP 1927 A AP1927 A AP 1927A
Authority
AP
ARIPO
Prior art keywords
infective compounds
indolepyridinium
substituted
substituted indolepyridinium
infective
Prior art date
Application number
AP2005003334A
Other languages
English (en)
Other versions
AP2005003334A0 (en
Inventor
Bart Rudolf Romanie Kesteleyn
De Vreken Wim Van
Natalie Maria Francisca Kindermans
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AP2005003334A0 publication Critical patent/AP2005003334A0/xx
Application granted granted Critical
Publication of AP1927A publication Critical patent/AP1927A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AP2005003334A 2002-11-15 2003-11-14 Substituted indolepyridinium as anti-infective compounds AP1927A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02079783 2002-11-15
US43495002P 2002-12-20 2002-12-20
PCT/EP2003/050837 WO2004046143A1 (en) 2002-11-15 2003-11-14 Substituted indolepyridinium as anti-infective compounds

Publications (2)

Publication Number Publication Date
AP2005003334A0 AP2005003334A0 (en) 2005-06-30
AP1927A true AP1927A (en) 2008-12-10

Family

ID=32327852

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003334A AP1927A (en) 2002-11-15 2003-11-14 Substituted indolepyridinium as anti-infective compounds

Country Status (16)

Country Link
US (2) US7608726B2 (no)
EP (1) EP1594870B1 (no)
JP (1) JP2006508145A (no)
KR (1) KR20050084621A (no)
CN (1) CN100457754C (no)
AP (1) AP1927A (no)
AU (1) AU2003296760B2 (no)
BR (1) BR0316209A (no)
CA (1) CA2506316A1 (no)
EA (1) EA009871B1 (no)
HR (1) HRP20050543A2 (no)
MX (1) MXPA05005146A (no)
NO (1) NO20052884L (no)
NZ (1) NZ540321A (no)
PL (1) PL376683A1 (no)
WO (1) WO2004046143A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
BRPI0511267A (pt) 2004-05-17 2007-11-27 Tibotec Pharm Ltd 1,5-diidropirido[3,2-b]indol-2-onas 4-substituìdas
AP2006003794A0 (en) * 2004-05-17 2006-10-31 Tibotec Pharm Ltd Combinations of substituted 1-phenyl-1,5-dihydropyrido-Ä3,2-bÜindol-2-ones and other HIV inhibitors
US20070238727A1 (en) * 2004-05-17 2007-10-11 Tibotec Bvba 5-Substituted 1-Phenyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones and Analogs as Anti-Virals
MXPA06013314A (es) * 2004-05-17 2007-02-02 Tibotec Pharm Ltd 1-heterociclil-1,5-dihidro-pirido[3,2-b]indol-2-onas.
WO2005111035A1 (en) * 2004-05-17 2005-11-24 Tibotec Pharmaceuticals Ltd. 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
CA2577467C (en) 2004-09-30 2013-05-28 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-heterocyclyl pyrimidines
RU2410379C2 (ru) 2004-09-30 2011-01-27 Тиботек Фармасьютикалз Лтд. 5-замещенные пиримидины, ингибирующие вич
AR056918A1 (es) 2005-01-10 2007-11-07 Tibotec Pharm Ltd 2-oxo-3-ciano-1,6a-diaza-tetrahidro-fluorantenos 1,5,6-sustituidos, proceso de preparacion del compuesto y composicion farmaceutica
WO2006082250A1 (en) * 2005-02-04 2006-08-10 Tibotec Pharmaceuticals Ltd. Screening method for competitive hiv rt inhibitors
JP2009525310A (ja) * 2006-02-03 2009-07-09 テイボテク・フアーマシユーチカルズ・リミテツド 突然変異したｈｉｖを処置する方法
EP2004632B1 (en) 2006-03-30 2014-03-12 Janssen R&D Ireland Hiv inhibiting 5-amido substituted pyrimidines
WO2008037783A1 (en) * 2006-09-29 2008-04-03 Tibotec Pharmaceuticals Ltd. Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles
US9006243B2 (en) 2006-12-29 2015-04-14 Janssen R&D Ireland HIV inhibiting 6-substituted pyrimidines
CN106045965A (zh) 2006-12-29 2016-10-26 爱尔兰詹森科学公司 抑制hiv的5,6‑取代的嘧啶类化合物
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
US8426434B2 (en) 2007-07-12 2013-04-23 Tibotec Pharmaceuticals Ltd. Crystalline form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
WO2010085582A1 (en) * 2009-01-23 2010-07-29 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
WO2010085584A1 (en) 2009-01-23 2010-07-29 Bristol-Myers Squibb Company Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists
WO2010085581A1 (en) * 2009-01-23 2010-07-29 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
MX2011010582A (es) 2009-04-09 2011-10-19 Boehringer Ingelheim Int Inhibidores de la replicacion del vih.
JP2013526496A (ja) * 2010-05-14 2013-06-24 アフェクティス ファーマシューティカルズ アーゲー Ｐ２ｘ７ｒ拮抗剤の新規調製方法
EP2599769A4 (en) 2010-07-28 2015-05-20 Sumitomo Chemical Co PROCESS FOR PREPARING A CARBOXYLIC ACID AMID
UA115576C2 (uk) 2012-12-06 2017-11-27 Байєр Фарма Акцієнгезелльшафт Похідні бензимідазолу як антагоністи ер4
MX2018006474A (es) * 2015-12-02 2018-08-01 Syngenta Participations Ag Derivados de oxadiazol microbicidas.
WO2017222951A1 (en) * 2016-06-23 2017-12-28 Merck Sharp & Dohme Corp. 3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
KR200486209Y1 (ko) 2016-07-05 2018-04-16 박우 편육 가공기구
CN108299428B (zh) * 2018-04-04 2019-09-27 山东大学 8-胺基-7-甲酸甲酯-吡嗪骈吡啶酮衍生物及其制备方法与应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055520A2 (en) * 2000-12-18 2002-07-18 Us Health Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
WO2002059123A2 (en) * 2000-12-18 2002-08-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055520A2 (en) * 2000-12-18 2002-07-18 Us Health Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
WO2002059123A2 (en) * 2000-12-18 2002-08-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds

Also Published As

Publication number Publication date
EA200500822A1 (ru) 2005-12-29
HRP20050543A2 (en) 2006-09-30
AU2003296760B2 (en) 2009-11-19
BR0316209A (pt) 2005-09-27
WO2004046143A1 (en) 2004-06-03
NO20052884D0 (no) 2005-06-14
MXPA05005146A (es) 2005-07-22
CN1738816A (zh) 2006-02-22
CN100457754C (zh) 2009-02-04
NO20052884L (no) 2005-08-15
US7608726B2 (en) 2009-10-27
PL376683A1 (pl) 2006-01-09
NZ540321A (en) 2007-09-28
CA2506316A1 (en) 2004-06-03
US20060173000A1 (en) 2006-08-03
EP1594870B1 (en) 2011-05-11
EA009871B1 (ru) 2008-04-28
AP2005003334A0 (en) 2005-06-30
AU2003296760A1 (en) 2004-06-15
EP1594870A1 (en) 2005-11-16
US20100048563A1 (en) 2010-02-25
KR20050084621A (ko) 2005-08-26
JP2006508145A (ja) 2006-03-09

Similar Documents

Publication Publication Date Title
AP2005003334A0 (en) Substituted indolepyridinium as anti-infective compounds
GB0305559D0 (en) Compounds
GB0305927D0 (en) Compound
GB0306718D0 (en) Compound
GB0304665D0 (en) Compounds
EP1689403A4 (en) HETEROARYL-hydrazone compounds
GB0324792D0 (en) Compound
GB0305553D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0317841D0 (en) Compound
GB0317842D0 (en) Compound
EP1682514A4 (en) 11-O-METHYLGELDANAMYCIN COMPOUNDS
GB0302512D0 (en) Compounds
GB0304494D0 (en) Compounds
GB0324599D0 (en) Compound
HK1085472A (en) Substituted indolepyridinium as anti-infective compounds
GB0307370D0 (en) Compounds I
GB0316107D0 (en) Compound
GB0318347D0 (en) Compound
GB0318345D0 (en) Compound
GB0315885D0 (en) Compound
GB0306717D0 (en) Compound
GB0300714D0 (en) Compound
GB0328509D0 (en) Compound
GB0330013D0 (en) Compound